cognitive impairment

The biomarker and clinical changes across the Alzheimer’s continuum study (BCAS): rationale, design, and baseline characteristics of the first 1,013 participants

Study Overview The BCAS study focuses on understanding the progression of Alzheimer’s disease through a comprehensive exploration of biomarker and […]

The biomarker and clinical changes across the Alzheimer’s continuum study (BCAS): rationale, design, and baseline characteristics of the first 1,013 participants Read Post »

Efficacy and safety of L-oxiracetam on cognitive function in patients with traumatic brain injury: a multicentre, randomised, double-blind, phase 3 clinical trial

Study Overview The recent multicentre, randomised, double-blind, phase 3 clinical trial investigated the efficacy and safety of L-oxiracetam in enhancing

Efficacy and safety of L-oxiracetam on cognitive function in patients with traumatic brain injury: a multicentre, randomised, double-blind, phase 3 clinical trial Read Post »

Within-Person Score Distribution Measures as Performance Validity Indicators in Service Members and Veterans with and without History of Mild Traumatic Brain Injury

Performance Validity Indicators Performance validity indicators (PVIs) are essential tools used to assess the credibility and reliability of cognitive performance

Within-Person Score Distribution Measures as Performance Validity Indicators in Service Members and Veterans with and without History of Mild Traumatic Brain Injury Read Post »

Scroll to Top